Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case report.

Hoff, Fieke W; Rolwes, John; Hardeman, Paula A; Perkins, Molly; Major, Eugene O; Douek, Daniel; Collins, Robert H; Greenberg, Benjamin M

Hoff, Fieke W; Rolwes, John; Hardeman, Paula A; Perkins, Molly; Major, Eugene O; Douek, Daniel; Collins, Robert H; Greenberg, Benjamin M.

Affiliation

Hoff FW; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Rolwes J; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.
Hardeman PA; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Perkins M; Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.
Major EO; Department of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
Douek D; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Collins RH; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Greenberg BM; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Ther Adv Hematol ; 14: 20406207231201721, 2023.

Article de En | MEDLINE | ID: mdl-37822572

Mots clés

IL-2; case report; follicular lymphoma; non-Hodgkin lymphoma; progressive multifocal leukoencephalopathy

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Risk_factors_studies Langue: En Journal: Ther Adv Hematol Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google